Swiss-based CorFlow is addressing one of the main unmet needs in cardiovascular: being able to diagnose and treat in a timely fashion Microvascular Obstructions (MVOs).

CorFlow introduces a groundbreaking solution as the first and only device capable of diagnosing MVO within two minutes during intervention and administering medication simultaneously, effectively resolving this critical issue.